| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6217907 Directly compressible high load acetaminophen formulations |
| 04/17/2001 | US6217897 Anhydrous spreadable mucoadhesive |
| 04/17/2001 | US6217889 Personal care articles |
| 04/17/2001 | US6217877 Extraction using water miscible solvent |
| 04/17/2001 | US6217875 Inhibitors of lipoxygenase |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/17/2001 | CA2152267C Difluoro-pentapeptide derivative anti-inflammatory agents |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025277A1 Single-chain antagonist polypeptides |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025219A2 Piperazine compounds |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024787A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO2001024778A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001005420A8 SMALL PEPTIDES AND METHODS FOR DOWNREGULATION OF IgE |
| 04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/12/2001 | WO2000069426A3 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | WO1999051735A3 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 04/12/2001 | DE19949043A1 Suppositories used for treating acute and chronic pain contain tramadol and diclofenac |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2387288A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386248A1 Il13 mutants |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090917A1 Quinolin-4-yl derivatives and their use as NMDA-receptor subtype blockers |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090636A1 High lipid diet |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090023A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090021A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090020A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090009A2 Cell adhesion-inhibiting antinflammatory compounds |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089973A1 Amidino and guanidino azetidinone tryptase inhibitors |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089751A1 Adjuvant therapy |
| 04/11/2001 | EP1089724A1 Therapeutic compositions and methods of use |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP1089713A1 Temperature-sensitive liposomal formulation |